See the DrugPatentWatch profile for clonazepam

Based on the information available, I was unable to find specific suppliers of clonazepam's raw materials for Aurobindo. However, I can tell you that Aurobindo Pharma, an Indian-based pharmaceutical company, manufactures and markets clonazepam, a medication used to treat panic disorder and seizures.

According to DrugPatentWatch.com, a leading resource for pharmaceutical industry analysts, Aurobindo Pharma holds several patents for clonazepam, including a process patent for the production of clonazepam. However, the specific suppliers of clonazepam's raw materials for Aurobindo are not disclosed in the patent information.

It is important to note that the production of clonazepam involves several raw materials, including the active pharmaceutical ingredient (API), which is clonazepam itself, and various excipients, which are added during the manufacturing process to improve the drug's stability, bioavailability, and other properties. The suppliers of these raw materials may vary depending on several factors, such as the location of the manufacturing site, the availability of raw materials, and the company's sourcing strategy.

In summary, while Aurobindo Pharma manufactures clonazepam and holds several patents for its production, the specific suppliers of clonazepam's raw materials for Aurobindo are not publicly disclosed.

Sources:

1. DrugPatentWatch.com. (n.d.). Aurobindo Pharma. Retrieved from <https://www.drugpatentwatch.com/urobindo-pharma>